Schoutsen B, De Jong J W, Harmsen E, De Tombe P P, Achterberg P W
Biochim Biophys Acta. 1983 Jul 14;762(4):519-24. doi: 10.1016/0167-4889(83)90055-1.
High-energy phosphates in heart muscle deprived of oxygen are rapidly broken down to purine nucleosides and oxypurines. We studied the role of xanthine oxidase/dehydrogenase (EC 1.2.3.2/EC 1.2.1.37) in this process with novel high-pressure liquid chromatographic techniques. Under various conditions, including ischemia and anoxia, the isolated perfused rat heart released adenosine, inosine and hypoxanthine, and also substantial amounts of xanthine and urate. Allopurinol, an inhibitor of xanthine oxidase, greatly enhanced the release of hypoxanthine. From the purine release we calculated that the rat heart contained about 18 mU xanthine oxidase per g wet weight. Subsequently, we measured a xanthine oxidase activity of 9 mU/g wet wt. in rat-heart homogenate. When endogenous low molecular weight inhibitors were removed by gel-filtration, the activity increased to 31 mU/g wet wt. Rat myocardial xanthine oxidase seems to be present mainly in the dehydrogenase form, which upon storage at -20 degrees C is converted to the oxidase form.
缺氧心肌中的高能磷酸盐迅速分解为嘌呤核苷和氧嘌呤。我们用新型高效液相色谱技术研究了黄嘌呤氧化酶/脱氢酶(EC 1.2.3.2/EC 1.2.1.37)在此过程中的作用。在包括缺血和缺氧在内的各种条件下,离体灌注大鼠心脏释放出腺苷、肌苷和次黄嘌呤,还释放出大量黄嘌呤和尿酸盐。黄嘌呤氧化酶抑制剂别嘌呤醇极大地增强了次黄嘌呤的释放。根据嘌呤释放量我们计算出大鼠心脏每克湿重约含18 mU黄嘌呤氧化酶。随后,我们测定大鼠心脏匀浆中黄嘌呤氧化酶活性为9 mU/g湿重。当通过凝胶过滤去除内源性低分子量抑制剂后,活性增加到31 mU/g湿重。大鼠心肌黄嘌呤氧化酶似乎主要以脱氢酶形式存在,在-20℃储存时会转化为氧化酶形式。